474 filings
Page 9 of 24
8-K
pbuk5
9 Aug 21
AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates
4:11pm
8-K
bfx3qd aksm1zzz
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:06pm
8-K
hwtidsio
3 Jun 21
Regulation FD Disclosure
12:00am
4
1re s8vjfko
13 May 21
ANAPTYSBIO / Hamza Suria ownership change
4:50pm
SC 13D/A
sjh4k565yeukoscli8
11 May 21
ANAPTYSBIO / EcoR1 Capital ownership change
4:08pm
4
4n4f9bv9i0ygnt28gx
4 May 21
ANAPTYSBIO / OLEG NODELMAN ownership change
4:51pm
8-K
cq9ir42ei6o74s3eprog
4 May 21
AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates
4:14pm
4
icv39pjv3 g06
27 Apr 21
ANAPTYSBIO / OLEG NODELMAN ownership change
6:23pm
DEFA14A
urdgibkywg2d5s3w1s
26 Apr 21
Additional proxy soliciting materials
4:02pm
SC 13D/A
doh08f7p3iuz7oyqf1eq
13 Apr 21
ANAPTYSBIO / EcoR1 Capital ownership change
12:00am
3
enyrz lnyf
12 Apr 21
ANAPTYSBIO / OLEG NODELMAN ownership change
4:20pm
8-K
afsj anxp
12 Apr 21
Departure of Directors or Certain Officers
4:05pm
4
vwj3e
10 Mar 21
Change in insider ownership
5:53pm
SC 13D
wzw1147
10 Mar 21
ANAPTYSBIO / EcoR1 Capital ownership change
5:17pm
SC 13D
r7ufp8c
10 Mar 21
ANAPTYSBIO / EcoR1 Capital Fund ownership change
5:02pm
8-K
wb7 345xamkn7leyvq
8 Mar 21
AnaptysBio Reports Imsidolimab POPLAR Phase 2 Clinical Trial in Moderate-to-Severe Palmoplantar Pustulosis (PPP) Did Not Meet
8:05am
4
b6momn6
25 Feb 21
Change in insider ownership
5:58pm
S-8
ogg60hhe5o012es
25 Feb 21
Registration of securities for employees
4:12pm